ÂÜÀòÂÒÂ×

Desmond Pink is the lead researcher in the development and validation of the Nanostics diagnostics platform and has considerable expertise in scientific team management, biochemistry, protein synthesis, and experimental therapeutics. Dr. Pink earned his Ph.D. in Nutrition and Metabolism at the University of Alberta in Edmonton, Alberta. Prior to joining Nanostics, he was the Senior Research Scientist and Project Manager at Entos Pharmaceuticals and Project Manager with Innovascreen Inc. Dr. Pink also investigated the cell signaling machinery of intestinal cancer cells as a Postdoctoral Fellow at Dalhousie University.